A new study found that a DNA sequencing test for advanced prostate cancer patients can distinguish between patients with poor and favorable prognoses.

Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found ...

Medically reviewed by Doru Paul, MD Multiple myeloma is a type of blood cancer that develops in plasma cells, a type of white ...

Eddie Jordan has revealed that he has been undergoing treatment for “aggressive” bladder and prostate cancer but added that ...

The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) will present new data showing a donor search prognosis score helps physicians move p ...

Postoperative complications have been reported to be a risk factor for worse oncologic outcomes in patients with esophageal cancer. However, the impact of postoperative complications on prognosis ...